Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Uprimny

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Cancers|November 11, 2022
A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-AnalysisRie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2019
Correction to: The <sup>68</sup>Ga/<sup>177</sup>Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-upJohanna Maffey-Steffan, Lorenza Scarpa, Anna Svirydenka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for <sup>68</sup>Ga-PSMA-11 PET/CTChristian Uprimny, Steffen Bayerschmidt, Alexander Stephan Kroiss, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 29, 2019
The <sup>68</sup>Ga/<sup>177</sup>Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-upJohanna Maffey-Steffan, Lorenza Scarpa, Anna Svirydenka, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 30, 2020
Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?Daniel Dejaco, Christian Uprimny, Gerlig Widmann, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CTSteffen Bayerschmidt, Christian Uprimny, Alexander Stephan Kroiss, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 17, 2018
Comparison of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT with [<sup>18</sup>F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapyChristian Uprimny, Anna Svirydenka, Josef Fritz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2025
Diagnostic Performance of the <sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine TumorsChristian Uprimny, Elisabeth von Guggenberg, Anna Sviridenko, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2012
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotideDaniel Putzer, Alexander Kroiss, Dietmar Waitz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2016
Early dynamic imaging in <sup>68</sup>Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesionsChristian Uprimny, Alexander Stephan Kroiss, Clemens Decristoforo, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Cancers|November 11, 2022
A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-AnalysisRie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2019
Correction to: The <sup>68</sup>Ga/<sup>177</sup>Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-upJohanna Maffey-Steffan, Lorenza Scarpa, Anna Svirydenka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for <sup>68</sup>Ga-PSMA-11 PET/CTChristian Uprimny, Steffen Bayerschmidt, Alexander Stephan Kroiss, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 29, 2019
The <sup>68</sup>Ga/<sup>177</sup>Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-upJohanna Maffey-Steffan, Lorenza Scarpa, Anna Svirydenka, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 30, 2020
Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?Daniel Dejaco, Christian Uprimny, Gerlig Widmann, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CTSteffen Bayerschmidt, Christian Uprimny, Alexander Stephan Kroiss, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 17, 2018
Comparison of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT with [<sup>18</sup>F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapyChristian Uprimny, Anna Svirydenka, Josef Fritz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2025
Diagnostic Performance of the <sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine TumorsChristian Uprimny, Elisabeth von Guggenberg, Anna Sviridenko, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2012
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotideDaniel Putzer, Alexander Kroiss, Dietmar Waitz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2016
Early dynamic imaging in <sup>68</sup>Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesionsChristian Uprimny, Alexander Stephan Kroiss, Clemens Decristoforo, et al.
Pageof 6